Literature DB >> 10589023

Distinct spatial and temporal distributions of aggrecan and versican in the embryonic chick heart.

M K Zanin1, J Bundy, H Ernst, A Wessels, S J Conway, S Hoffman.   

Abstract

Although chondroitin sulfate proteoglycans (CSPGs) are major components of the embryonic extracellular matrix, little attention has been paid to specific CSPGs in early heart development, in part because appropriate antibodies were not available. Therefore we prepared specific polyclonal antibodies against chicken aggrecan, versican, neurocan, and phosphacan. Western blotting and immunohistochemical studies revealed the presence of aggrecan and versican in stages 12-21 chicken embryo hearts in distinctive spatial and temporal patterns. Because this is the first demonstration of aggrecan in heart tissue, we further used RT-PCR to confirm that aggrecan is expressed in the heart and in situ hybridization to confirm the pattern of expression determined using antibodies. Versican is found in the myocardium and the myocardial basement membrane. In contrast, aggrecan is specifically colocalized with several groups of migrating cells including endocardial cushion tissue cells, epicardial cells, a mesenchymal cell population in the outflow tract that may be of neural crest origin, and a mesenchymal cell population in the inflow tract. The combined observations indicate that versican and aggrecan are expressed in unique patterns and suggest that they play very different roles in development. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1999        PMID: 10589023     DOI: 10.1002/(SICI)1097-0185(19991201)256:4<366::AID-AR4>3.0.CO;2-#

Source DB:  PubMed          Journal:  Anat Rec        ISSN: 0003-276X


  21 in total

1.  Proteolytic cleavage of versican during cardiac cushion morphogenesis.

Authors:  Christine B Kern; Waleed O Twal; Corey H Mjaatvedt; Sarah E Fairey; Bryan P Toole; M Luisa Iruela-Arispe; W Scott Argraves
Journal:  Dev Dyn       Date:  2006-08       Impact factor: 3.780

2.  Versican proteolysis mediates myocardial regression during outflow tract development.

Authors:  Christine B Kern; Russell A Norris; Robert P Thompson; W Scott Argraves; Sarah E Fairey; Leticia Reyes; Stanley Hoffman; Roger R Markwald; Corey H Mjaatvedt
Journal:  Dev Dyn       Date:  2007-03       Impact factor: 3.780

Review 3.  Extracellular matrix and heart development.

Authors:  Marie Lockhart; Elaine Wirrig; Aimee Phelps; Andy Wessels
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-05-25

4.  Versican knockdown reduces interzone area during early stages of chick synovial joint development.

Authors:  Partha S Nagchowdhuri; Kristen N Andrews; Savannah Robart; Anthony A Capehart
Journal:  Anat Rec (Hoboken)       Date:  2011-12-20       Impact factor: 2.064

5.  Differentiation of cardiomyocytes from human embryonic stem cells is accompanied by changes in the extracellular matrix production of versican and hyaluronan.

Authors:  Christina K Chan; Marsha W Rolle; Susan Potter-Perigo; Kathleen R Braun; Benjamin P Van Biber; Michael A Laflamme; Charles E Murry; Thomas N Wight
Journal:  J Cell Biochem       Date:  2010-10-15       Impact factor: 4.429

Review 6.  What chick and mouse models have taught us about the role of the endocardium in congenital heart disease.

Authors:  Daniel M DeLaughter; Leshana Saint-Jean; H Scott Baldwin; Joey V Barnett
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-04-28

7.  Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart.

Authors:  Paige Snider; Robert B Hinton; Ricardo A Moreno-Rodriguez; Jian Wang; Rhonda Rogers; Andrew Lindsley; Fang Li; David A Ingram; Donald Menick; Loren Field; Anthony B Firulli; Jeffery D Molkentin; Roger Markwald; Simon J Conway
Journal:  Circ Res       Date:  2008-02-22       Impact factor: 17.367

8.  Reduced versican cleavage due to Adamts9 haploinsufficiency is associated with cardiac and aortic anomalies.

Authors:  Christine B Kern; Andy Wessels; Jessica McGarity; Laura J Dixon; Ebony Alston; W Scott Argraves; Danielle Geeting; Courtney M Nelson; Donald R Menick; Suneel S Apte
Journal:  Matrix Biol       Date:  2010-01-22       Impact factor: 11.583

9.  Chondroitin sulfate expression is required for cardiac atrioventricular canal formation.

Authors:  David S Peal; C Geoffrey Burns; Calum A Macrae; David Milan
Journal:  Dev Dyn       Date:  2009-12       Impact factor: 3.780

Review 10.  Aggrecan in Cardiovascular Development and Disease.

Authors:  Christopher D Koch; Chan Mi Lee; Suneel S Apte
Journal:  J Histochem Cytochem       Date:  2020-09-01       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.